Myocardial Smad4 is essential for cardiogenesis in mouse embryos

Lanying Song, Wensheng Yan, Xinbin Chen, Chu Xia Deng, Qin Wang, Kai Jiao

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Congenital heart diseases are the most commonly observed human birth defects and are the leading cause of infant morbidity and mortality. Accumulating evidence indicates that transforming growth factor-β/bone morphogenetic protein signaling pathways play critical roles during cardiogenesis. Smad4 encodes the only common Smad protein in mammals, which is a critical nuclear mediator of transforming growth factor-β/bone morphogenetic protein signaling. The aim of this work was to investigate the roles of Smad4 during heart development. To overcome the early embryonic lethality of Smad4 mice, we specifically disrupted Smad4 in the myocardium using a Cre/loxP system. We show that myocardial-specific inactivation of Smad4 caused heart failure and embryonic lethality at midgestation. Histological analysis revealed that mutant mice displayed a hypocellular myocardial wall defect, which is likely the primary cause for heart failure. Both decreased cell proliferation and increased apoptosis contributed to the myocardial wall defect in mutant mice. Data presented in this article contradict a previous report showing that Smad4 is dispensable for heart development. Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos. Reporter analysis indicated that the transcriptional activity of the 351-bp Nmyc promoter can be positively regulated by bone morphogenetic protein stimulation and negatively regulated by transforming growth factor-β stimulation. Chromatin immunoprecipitation analysis revealed that the Nmyc promoter can form a complex with Smad4, suggesting that Nmyc is a direct downstream target of Smad4. In conclusion, this study provides the first mouse model showing that Smad4 plays essential roles during cardiogenesis.

Original languageEnglish (US)
Pages (from-to)277-285
Number of pages9
JournalCirculation Research
Volume101
Issue number3
DOIs
StatePublished - Aug 2007
Externally publishedYes

Fingerprint

Bone Morphogenetic Proteins
Transforming Growth Factors
Embryonic Structures
Smad4 Protein
Heart Failure
Cyclin D2
Smad Proteins
Critical Pathways
Chromatin Immunoprecipitation
Cyclin D1
Infant Mortality
Mammals
Heart Diseases
Myocardium
Down-Regulation
Cell Proliferation
Apoptosis
Morbidity

Keywords

  • Cardiogenesis
  • Myocardium
  • Nmyc
  • Smad4
  • Transforming growth factor β/bone morphogenetic protein

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Myocardial Smad4 is essential for cardiogenesis in mouse embryos. / Song, Lanying; Yan, Wensheng; Chen, Xinbin; Deng, Chu Xia; Wang, Qin; Jiao, Kai.

In: Circulation Research, Vol. 101, No. 3, 08.2007, p. 277-285.

Research output: Contribution to journalArticle

Song, Lanying ; Yan, Wensheng ; Chen, Xinbin ; Deng, Chu Xia ; Wang, Qin ; Jiao, Kai. / Myocardial Smad4 is essential for cardiogenesis in mouse embryos. In: Circulation Research. 2007 ; Vol. 101, No. 3. pp. 277-285.
@article{93093cc90ae7481aa3dbc2c146fc9c98,
title = "Myocardial Smad4 is essential for cardiogenesis in mouse embryos",
abstract = "Congenital heart diseases are the most commonly observed human birth defects and are the leading cause of infant morbidity and mortality. Accumulating evidence indicates that transforming growth factor-β/bone morphogenetic protein signaling pathways play critical roles during cardiogenesis. Smad4 encodes the only common Smad protein in mammals, which is a critical nuclear mediator of transforming growth factor-β/bone morphogenetic protein signaling. The aim of this work was to investigate the roles of Smad4 during heart development. To overcome the early embryonic lethality of Smad4 mice, we specifically disrupted Smad4 in the myocardium using a Cre/loxP system. We show that myocardial-specific inactivation of Smad4 caused heart failure and embryonic lethality at midgestation. Histological analysis revealed that mutant mice displayed a hypocellular myocardial wall defect, which is likely the primary cause for heart failure. Both decreased cell proliferation and increased apoptosis contributed to the myocardial wall defect in mutant mice. Data presented in this article contradict a previous report showing that Smad4 is dispensable for heart development. Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos. Reporter analysis indicated that the transcriptional activity of the 351-bp Nmyc promoter can be positively regulated by bone morphogenetic protein stimulation and negatively regulated by transforming growth factor-β stimulation. Chromatin immunoprecipitation analysis revealed that the Nmyc promoter can form a complex with Smad4, suggesting that Nmyc is a direct downstream target of Smad4. In conclusion, this study provides the first mouse model showing that Smad4 plays essential roles during cardiogenesis.",
keywords = "Cardiogenesis, Myocardium, Nmyc, Smad4, Transforming growth factor β/bone morphogenetic protein",
author = "Lanying Song and Wensheng Yan and Xinbin Chen and Deng, {Chu Xia} and Qin Wang and Kai Jiao",
year = "2007",
month = "8",
doi = "10.1161/CIRCRESAHA.107.155630",
language = "English (US)",
volume = "101",
pages = "277--285",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Myocardial Smad4 is essential for cardiogenesis in mouse embryos

AU - Song, Lanying

AU - Yan, Wensheng

AU - Chen, Xinbin

AU - Deng, Chu Xia

AU - Wang, Qin

AU - Jiao, Kai

PY - 2007/8

Y1 - 2007/8

N2 - Congenital heart diseases are the most commonly observed human birth defects and are the leading cause of infant morbidity and mortality. Accumulating evidence indicates that transforming growth factor-β/bone morphogenetic protein signaling pathways play critical roles during cardiogenesis. Smad4 encodes the only common Smad protein in mammals, which is a critical nuclear mediator of transforming growth factor-β/bone morphogenetic protein signaling. The aim of this work was to investigate the roles of Smad4 during heart development. To overcome the early embryonic lethality of Smad4 mice, we specifically disrupted Smad4 in the myocardium using a Cre/loxP system. We show that myocardial-specific inactivation of Smad4 caused heart failure and embryonic lethality at midgestation. Histological analysis revealed that mutant mice displayed a hypocellular myocardial wall defect, which is likely the primary cause for heart failure. Both decreased cell proliferation and increased apoptosis contributed to the myocardial wall defect in mutant mice. Data presented in this article contradict a previous report showing that Smad4 is dispensable for heart development. Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos. Reporter analysis indicated that the transcriptional activity of the 351-bp Nmyc promoter can be positively regulated by bone morphogenetic protein stimulation and negatively regulated by transforming growth factor-β stimulation. Chromatin immunoprecipitation analysis revealed that the Nmyc promoter can form a complex with Smad4, suggesting that Nmyc is a direct downstream target of Smad4. In conclusion, this study provides the first mouse model showing that Smad4 plays essential roles during cardiogenesis.

AB - Congenital heart diseases are the most commonly observed human birth defects and are the leading cause of infant morbidity and mortality. Accumulating evidence indicates that transforming growth factor-β/bone morphogenetic protein signaling pathways play critical roles during cardiogenesis. Smad4 encodes the only common Smad protein in mammals, which is a critical nuclear mediator of transforming growth factor-β/bone morphogenetic protein signaling. The aim of this work was to investigate the roles of Smad4 during heart development. To overcome the early embryonic lethality of Smad4 mice, we specifically disrupted Smad4 in the myocardium using a Cre/loxP system. We show that myocardial-specific inactivation of Smad4 caused heart failure and embryonic lethality at midgestation. Histological analysis revealed that mutant mice displayed a hypocellular myocardial wall defect, which is likely the primary cause for heart failure. Both decreased cell proliferation and increased apoptosis contributed to the myocardial wall defect in mutant mice. Data presented in this article contradict a previous report showing that Smad4 is dispensable for heart development. Our further molecular characterization showed that expression of Nmyc and its downstream targets, including cyclin D1, cyclin D2, and Id2, were downregulated in mutant embryos. Reporter analysis indicated that the transcriptional activity of the 351-bp Nmyc promoter can be positively regulated by bone morphogenetic protein stimulation and negatively regulated by transforming growth factor-β stimulation. Chromatin immunoprecipitation analysis revealed that the Nmyc promoter can form a complex with Smad4, suggesting that Nmyc is a direct downstream target of Smad4. In conclusion, this study provides the first mouse model showing that Smad4 plays essential roles during cardiogenesis.

KW - Cardiogenesis

KW - Myocardium

KW - Nmyc

KW - Smad4

KW - Transforming growth factor β/bone morphogenetic protein

UR - http://www.scopus.com/inward/record.url?scp=34548359388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548359388&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.107.155630

DO - 10.1161/CIRCRESAHA.107.155630

M3 - Article

VL - 101

SP - 277

EP - 285

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 3

ER -